Tempest Therapeutics, Inc. (TPST) Tops Q3 EPS by 9c

Tempest Therapeutics, Inc. (NASDAQ: TPST) reported Q3 EPS of ($0.48), $0.09 better than the analyst estimate of ($0.57).

For earnings history and earnings-related data on Tempest Therapeutics, Inc. (TPST) click here.

You May Also Be Interested In

• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
• Visteon (VC) PT Raised to $135 at TD Cowen
• Jefferies Assumes Allied Blenders (ABDL:IN) at Buy